NCT05841862View on ClinicalTrials.gov

Intravitreal Quantum Dots (QD) for Advanced Retinitis Pigmentosa (RP) (QUANTUM)

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 20, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Retinitis Pigmentosa
Interventions
DEVICE

2C-QD

Quantum Dot

DEVICE

Sham 2C-QD

Sham Intravitreal Injection

Sponsors

Lead Sponsor

2C Tech Corp
All Listed Sponsors
collaborator

ORA, Inc.

INDUSTRY

lead

2C Tech Corp

INDUSTRY